Gilead Sciences Stock Analysis, Valuation (NASDAQ:GILD)
Gilead Sciences Stock Analysis
View Gilead Sciences stock analysis video. This is our analyst opinion covering the buy and sell arguments for GILD stock.
Gilead Sciences, Inc. Stock Rating 4.3/5
Our Gilead Sciences stock opinion is based on fundamentals of the company. This Gilead Sciences stock analysis is based on latest 2017 Q2 earnings. The stock price analysis takes into account the company's valuation metrics.
Should you buy GILD stock?
- The TTM operating margin was good at 57.8% for Gilead Sciences.
- LTM Net margins were good at 42.9% for Gilead Sciences.
- The price to earnings multiple of 8.3 is attractive when compared with the industry average PE ratio of 22.8.
- Gilead Sciences has an attractive ROIC (Return on Invested Capital) of 37.7%
- The LTM ROE of 63.1% for Gilead Sciences is attractive.
- Gilead Sciences has a healthy FCF (Free Cash Flow) margin of 47.7%.